Autolus Therapeutics plc (FRA:6A3A)
Germany · Delayed Price · Currency is EUR 1.360
-0.040 (-2.86%)
At close: Jun 26, 2026
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of €375.7 million as of June 26, 2026. Its market cap has decreased by -27.62% in one year.
Market Cap
375.70M
Enterprise Value
498.18M
Revenue
80.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.36
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from 833.42M to 375.70M, a decrease of -54.92%. That is a compound annual growth rate of -9.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 375.70M | -16.71% |
| Dec 31, 2025 | 451.08M | -25.33% |
| Dec 31, 2024 | 604.06M | -40.39% |
| Dec 29, 2023 | 1.01B | 229.38% |
| Dec 30, 2022 | 307.67M | -7.54% |
| Dec 31, 2021 | 332.77M | -12.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Darwin AG | 95.40M |
| 2invest AG | 44.96M |
| Biomark Diagnostics | 33.65M |
| Vidac Pharma Holding | 24.99M |
| co.don AG | 414.21K |
| Paion AG | 385.22K |
| bioXXmed AG | 222.93K |